Annual charity drive raises £17,000 for Cancer Research UK

Lanes Group’s annual charity fundraising campaign has raised over £17,000 for Cancer Research UK.

A final totalling up of all donations made has shown that hundreds of staff, plus their families and friends, raised £8,500.10 for the charity during 2015.

When combined with Lanes Group’s pledge to match the money raised by staff, the total amount that will go to Cancer Research UK is £17,001 and 10 pence.

Staff are now raising donations for the Lanes Group company charity for 2016, which is Macmillan Cancer Support.

Lanes Group Managing Director Wayne Earnshaw said: “We’re delighted that, between us, we have raised so much money for Cancer Research UK, which is at the forefront of the battle against cancer.

“Our staff showed their generous spirit, in terms of donating both time and money to the cause to support Cancer Research UK. It was a great effort by all.

“Lanes Group and our staff are serious about wanting to support the communities where we work, and we’re now doing all we can to help Macmillan Cancer Support in the same way.”

Lanes staff vote on which good cause will be the company charity of the year, and in 2015 Cancer Research UK was selected for the second year running.

Throughout the 12 months, staff – in groups and as individuals – raised money by completing sponsored bike rides, fun runs, bake sales and Wimbledon lunches.

For example, Ann Grant, from the Lanes Sevenoaks depot raised £300 by completing a Cancer Research UK 100 kilometre Ride the Night bike ride.

The Lanes Group marketing team took part in the Manchester Color Run, raising a total of £1997.25.

Claire Booth, based at the Lanes Manchester office, and Jenna Hawkswell, based in Leeds, took part in the charity’s Pretty Muddy Race for Life, raising £155 and £700 respectively.

Other colleagues brought in unwanted items, including books, ornaments and clothes to be sent to Cancer Research UK charity shops.

Cancer Research UK is at the centre of world-leading research in the UK, which is continuously contributing to new cancer therapies.

Recent figures show that death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 years, thanks to research.

In June 2016, Cancer Research UK announced its scientists had found a new way to slow the growth of the most aggressive type of breast cancer.